Modulation of multidrug resistance 1 expression and function in retinoblastoma cells by curcumin

Journal of Pharmacology and Pharmacotherapeutics

Volumn 4, Issue 2, 2013, Pages 103-109

  Sreenivasan, Seethalakshmi ^a   Ravichandran, Sathyabaarathi ^a   Vetrivel, Umashankar ^a   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

Multidrug resistance; p glycoprotein; retinoblastoma; Y79

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; BIOTIN; CURCUMIN; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; VERAPAMIL;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; COMPUTER MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DOCKING; MOLECULAR MODEL; MULTIDRUG RESISTANCE; PHOTOAFFINITY LABELING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84877107877     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.110882     Document Type: Article

References (28)

1. Krishnakumar S, Mallikarjuna K, Desai N, Muthialu A, Venkatesan N, Sundaram A, et al. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. Br J Ophthalmol 2004;88:1521-6.
2. Van Brussel JP, Van Steenbrugge GJ, Romijn JC, Schroder FH, Mickisch GH. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur J Cancer 1999;35:664-71.
3. Choi CH. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 2005;5:30.
4. Chan HS, Thorner PS, Haddad G, Gallie B. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology 1991;98:1425-31.
5. Tan B, Piwnica-Worms D, Rater L. Multidrug resistance transporters and modulation. Curr Opin Oncol 2000;12:450-8.
6. Oh KT, Baik HJ, Lee AH, Oh YT, Youn YS, Lee ES. The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system. Int J Mol Sci 2009;10:3776-92.
7. Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol 2004;68:2043-52.
8. Dawson RJ, Locher KP. Structure of a bacterial multidrug ABC transporter. Nature 2006;443:180-5.
9. Eswar N, Eramian D, Webb B, Shen MY, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol 2008;426:145-59.
10. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: Fast, flexible, and free. J Comput Chem 2005;26:1701-18.
11. Summa CM, Levitt M. Near-native structure refinement using in vacuo energy minimization. Proc Natl Acad Sci USA 2007;104:3177-82.
12. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283-91.
13. Wiederstein M, Sippl MJ. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407-10.
14. Xu J, Zhang Y. How significant is a protein structure similarity with TM-score = 0.5? Bioinformatics 2010;26:889-95.
15. Tan KP, Varadarajan R, Madhusudhan MS. DEPTH: A web server to compute depth and predict small-molecule binding cavities in proteins. Nucleic Acids Res 2011;39:W242-8.
16. Vetrivel U, Subramanian N, Pilla K. InPACdb: Indian plant anticancer compounds database. Bioinformation 2009;5:71-4.
17. Schüttelkopf AW, van Aalten DM. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 2004;60:1355-63.
18. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: Applications of AutoDock. J Mol Recognit 1996;9:1-5.
19. Corbeil CR, Englebienne P, Moitessier N. Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0. J Chem Inf Model 2007;47:435-49.
20. Vetrivel U, Pilla K. Open discovery: An integrated live Linux platform of Bioinformatics tools. Bioinformation 2008;3:144-6.
21. Arceci RJ. Tumor cell survival and resistance to therapy. Curr Opin Hematol 1996;3:279-87.
22. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002;64:573-82.
23. Sreenivasan S, Ravichandran S, Vetrivel U, Krishnakumar S. In vitro and In silico studies on inhibitory effects of curcumin on multi-drug resistance associated protein (MRP1) in retinoblastoma cells. Bioinformation 2012;8:13-9.
24. Thiyagarajan S, Thirumalai V, Nirmala S Biswas J, Krishnakumar S. Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells. Curr Eye Res 2009;34:845-51.
25. Romiti N, Tongiani R, Cervelli F, Chieli E. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 1998;62:2349-58.
26. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
27. Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, et al. Reversal of P-gp mediated multidrug resistance in vitro and in vivo by FG020318. J Pharm Pharmacol 2004;56:1061-6.
28. Tang XQ, Bi H, Feng JQ, Cao JG. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol Sin 2005;26:1009-16.